eli lilly glp 1 drug FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - FDA approves new weight-loss pill,

Thats why the FDA gives it a boxed warning

Blue Cross Blue Shield of Massachusetts will soon stop covering popular drugs for weight loss, like Ozempic.

Wegovy, the GLP-1 medication to treat obesity from Lilly competitor Novo Nordisk, will still be covered under plans managed by CVS Caremark.

Navigate the challenges of GLP-1 medications and constipation on your weight loss journey with expert insights from LifeRx.md, Inc

Insurers raised cost-sharing sharply for GLP-1s in recent years and also increased use of prior authorization.

altRx GLP-1 Injections are customized GLP-1 therapy designed for individuals who benefit from a formulation aligned with their specific health goals